Optimal use of proton pump inhibitors for treating acid peptic diseases in primary care

被引：0

作者：

Tack, J. ^{[1
]}

Louis, E. ^{[2
,3
]}

Persy, V. ^{[4
]}

Urbain, D. ^{[5
]}

机构：

[1] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders, B-3000 Louvain, Belgium

[2] CHU, Liege, Belgium

[3] Univ Liege, Liege, Belgium

[4] Hugin Mugin Res, Antwerp, Belgium

[5] Vrije Univ Brussel, UZ Brussel, Dept Gastroenterol, Brussels, Belgium

来源：

ACTA GASTRO-ENTEROLOGICA BELGICA | 2013年 / 76卷 / 04期

关键词：

Proton pump inhibitors; acid peptic diseases; best practices; review; GASTROESOPHAGEAL-REFLUX DISEASE; FUNCTIONAL DYSPEPSIA; HELICOBACTER-PYLORI; CLINICAL-TRIALS; ESOPHAGEAL PH; PPI THERAPY; LIFE-STYLE; SYMPTOMATIC PATIENTS; GENERAL-POPULATION; DOUBLE-BLIND;

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Heartburn, reflux and epigastric pain are frequently encountered symptoms in primary care medicine. Acid peptic diseases such as peptic ulcer and gastrointestinal reflux disease have a high prevalence, can have important impact on patient quality of life and represent a considerable health care cost. Proton pump inhibitors (PPIs) are the most potent pharmacological inhibitors of gastric acid secretion currently available and are the mainstay medical therapy for acid peptic diseases. This review summarizes current evidence on treatment of acid-peptic diseases with proton pump inhibitors and provides primary care clinicians with best practice guidelines for optimal use of these drugs.

引用

页码：393 / 402

页数：10

共 50 条

[21] An evaluation of the use of proton pump inhibitors
Walker, NM
McDonald, J
PHARMACY WORLD & SCIENCE, 2001, 23 (03): : 116 - 117
[22] An evaluation of the use of proton pump inhibitors
N.M. Walker
J. McDonald
Pharmacy World and Science, 2001, 23 : 116 - 117
[23] Analysis of proton pump inhibitors anti-ulcer drugs use in the Araba district primary care area
Martinez Gorostiaga, Javier
Echevarria Orella, Enrique
Calvo Hernaez, Begona
REVISTA ESPANOLA DE SALUD PUBLICA, 2018, 92
[24] Clinical trial: long-term use of proton pump inhibitors in primary care patients - a cross sectional analysis of 901 patients
Reimer, C.
Bytzer, P.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (07) : 725 - 732
[25] Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD
Holtmann, Gerald
Bigard, Marc-Andre
Malfertheiner, Peter
Pounder, Roy
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (03) : 493 - 500
[26] Indications for the Use of Proton Pump Inhibitors for Stress Ulcer Prophylaxis and Peptic Ulcer Bleeding in Hospitalized Patients
Clarke, Karen
Adler, Nicole
Agrawal, Deepak
Bhakta, Dimpal
Sata, Suchita Shah
Singh, Sarguni
Gupta, Arjun
Pahwa, Amit
Pherson, Emily
Sun, Alexander
Volpicelli, Frank
Cho, Hyung J.
AMERICAN JOURNAL OF MEDICINE, 2022, 135 (03): : 313 - 317
[27] Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship
Dutta, Amit Kumar
Jain, Abhinav
Jearth, Vaneet
Mahajan, Ramit
Panigrahi, Manas Kumar
Sharma, Vishal
Goenka, Mahesh Kumar
Kochhar, Rakesh
Makharia, Govind
Reddy, Duvvur Nageshwar
Kirubakaran, Richard
Ahuja, Vineet
Berry, Neha
Bhat, Naresh
Dutta, Usha
Ghoshal, Uday Chand
Jain, Ajay
Jalihal, Umesh
Jayanthi, V.
Kumar, Ajay
Nijhawan, Sandeep
Poddar, Ujjal
Ramesh, G. N.
Singh, Shivram P.
Zargar, Showkat
Bhatia, Shobna
INDIAN JOURNAL OF GASTROENTEROLOGY, 2023, 42 (05) : 601 - 628
[28] The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal
Savarino, Vincenzo
Dulbecco, Pietro
de Bortoli, Nicola
Ottonello, Andrea
Savarino, Edoardo
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 37 : 19 - 24
[29] Deprescribing Proton Pump Inhibitors in an Academic, Primary Care Clinic Quality Improvement Project
Nallapeta, Naren
Reynolds, Jessica L.
Bakhai, Smita
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2020, 54 (10) : 864 - 870
[30] Proton Pump Inhibitors - Their Pharmacological Impact on the Clinical Management of Acid-Related Disorders
Klotz, Ulrich
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2009, 59 (06): : 271 - 282

← 1 2 3 4 5 →